Key facts
- Laguna Tech USA’s last known valuation is $24.5M (Dec 2025).
- It has raised $8.3M across 3 recorded rounds; the latest was Seed Round ($3.3M) in Dec 2025.
- Notable investors include MedTech Innovator.
- Laguna Tech USA has filed 3 Form Ds with the SEC since 2022, most recently Dec 2025 ($3.3M sold to 1 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Laguna Tech USA
Funding rounds
3 roundsAbout Laguna Tech USA
Developer of heart valve replacement technology designed to revolutionize treatment options for aortic stenosis and regurgitation. The company's device combines the benefits of balloon-expandable and self-expanding technologies, offering features like simplicity, reliability, and precise deployment, enabling medical professionals to provide improved patient outcomes through minimally invasive procedures.
- Sector
- Healthcare
- HQ
- Irvine, CA, United States
- Founded
- 2022
- Employees
- 3
- Website
- lagunatechmed.com/
- Ownership
- Privately Held (backing)
Laguna Tech USA doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Laguna Tech USA shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Laguna Tech USA in its N-PORT filings yet. We sweep new filings monthly.